Researchmoz added new market research report on "Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 - Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat Market, Trends, Share, Size Research Report " to its store. GBI Research has released its pharmaceutical research, "Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 – Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat", which provides insights into three cardiovascular therapeutic indications in the top eight markets of the US, the UK, Germany, France, Italy, Spain, Japan and Canada. The report provides an in-depth analysis of the cardiovascular therapeutic indications, namely heart failure, myocardial infarction (MI), acute coronary syndrome (ACS). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these three cardiovascular indications.
Scope
Disease overview and treatment usage patterns
Market size and forecast for heart failure, Myocardial Infarction (MI) and Acute Coronary Syndrome (ACS)
Geographic coverage includes the top eight markets (the US, the UK, Germany, France, Italy, Spain, Japan and Canada) from 2012 to 2019
Major marketed products for the indications types covered
In-depth pipeline analysis for heart failure, MI and ACS
Key drivers and restraints that have had and are expected to have a significant impact upon the market
Key licensing and co-development agreements in the cardiovascular market
Reasons to Buy
The report will enhance your decision-making capability by allowing you to:
Align your product portfolio to the markets with high growth potential
Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the cardiovascular market
Develop key strategic initiatives based upon an understanding of key focus areas and leading companies
Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships
Complete Copy of this Report At: http://www.researchmoz.us/cardiovascular-diseases-therapeutics-in-major-developed-markets-to-2019-increasing-prevalence-and-promising-novel-drugs-offset-patent-cliff-threat-report.html
Contact
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us